“Sometimes it is the simplest things in medicine that stay the same over time,” says Liu, whose invention will be featured later this week at Boston Children’s Hospital’s Global Pediatric Innovation Summit + Awards 2014 (October 30-31). Full story »
From the category archives:
For years, that kind of thinking has been the domain of dreams. Little is known about infant brains, largely because sophisticated neuroimaging technology simply hasn’t been designed with infants in mind. Boston Children’s Hospital’s Ellen Grant, MD, and Yoshio Okada, PhD, are debuting a new magnetoencephalography (MEG) system designed to turn those dreams into reality. Full story »
The hackathon, produced by Boston Children’s Hospital in collaboration with MIT Hacking Medicine, brought out many common themes: Helping kids with chronic illnesses track their symptoms, take their meds and avoid lots of clinic visits. Helping parents coordinate their children’s care and locate resources. Helping pediatric clinicians make better decisions with the right information at the right time.
It’s a great infotainment formula—even my 10-year-old daughter is a fan—but it’s also a hit beyond the living room. Health care organizations are increasingly borrowing the “Shark Tank” script to get new ideas or to bankroll their own innovations. Boston Children’s Hospital is doing so at our Global Pediatric Innovation Summit + Awards (Oct. 30-31), bringing in “Shark Tank”’s Daymond John to moderate. But we’re certainly not alone. In recent months: Full story »
$100 plastic car stands in for $25,000 power wheelchair
In the first (and likely only) National Institutes of Health-funded shopping spree at Toys R’ Us, Cole Galloway, director of the Pediatric Mobility Lab at the University of Delaware, and crew stocked up on pint-sized riding toys.
Galloway’s quest was to facilitate independence and mobility among disabled children from the age of six months and older and offer a low-tech solution during the five-year wait in the United States for a $25,000 power pediatric wheelchair.
The hackers jerry-rigged the toys with pool noodles, PVC pipe and switches, reconfiguring them as mobile rehabilitation devices to promote functional skills among kids with special needs. Full story »
Naomi Fried, PhD, Chief Innovation Officer at Boston Children’s Hospital, will lead a panel on Innovation Acceleration at Taking on Tomorrow: Global Pediatric Innovation Summit + Awards (October 30-31, Seaport World Trade Center, Boston). Register now!
The word innovation gets thrown around a lot these days by people trying to set their products and ideas apart in the marketplace. But when everything is innovative, is anything really innovative? And if there really are innovative ideas, are they simply flashes of brilliance that can’t be planned for or predicted?
The answer to this last question is “no,” as I see every day at Boston Children’s Hospital, where I lead the Innovation Acceleration Program. The real trick is creating an innovation culture that supports great ideas—but that also supports the not-so-great ideas that teach us almost as much.
So what are the attributes of an innovation culture? Full story »
Health care is plagued by problems that aren’t necessarily sexy or compelling, says Mandira Singh, MBA, of AthenaHealth, who will speak at the Summit’s Mobile & Digital Health panel. More than many other industries, it still depends on outdated technology. For example, it’s the only industry that continues to rely on fax machines. “These are small problems that need to be fixed,” Singh said recently at a Boston Children’s Hospital forum.
Instead of focusing on everyday challenges, innovators often think far out into the future—to where they think health care will be in 10 years. That can be a trap: Full story »
Technology sometimes unfolds at a slow, measured pace and sometimes at lightning speed. Right now, we are witnessing what is arguably one of the fastest moving fields in biomedical science: a form of genome editing aptly known as CRISPR.
CRISPR allows researchers to make very precise—some would say crisp—changes to the genomes of human cells and those of other organisms. You might think of it as a kind of guided missile. Its precision is opening the doors to a wide variety of research and, hopefully, medical applications. Indeed, the possibilities seem to be bound only by scientists’ imaginations.
“For a long time, we have been accumulating new knowledge about which gene mutation causes which disease. But until very recently, we haven’t had the ability to go in and correct those mutations,” explains Feng Zhang, PhD, a core member of the Broad Institute of Harvard and MIT, and one of the method’s pioneers. “CRISPR is one of the tools that is starting to allow us to directly go in and do surgery on the genome and replace the mutations.”
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. While this name is a bit verbose, it points to the technology’s origins: a set of genetic sequences first discovered in bacteria. Full story »